Melanoma Clinical Trial

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

Summary

This study will collect real-world data from advanced melanoma diagnosis through most recent visit and data sourced from patient medical records following a 2-part study design consisting of a random sample (Part 1) and an oversample (Part 2).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults 18 years or older
Diagnosis of unresectable stage III and/or metastatic (stage IV) melanoma before 01-Nov-2015
Initiating a new line of therapy during the index period between 01-Jan-2015 and 31-May-2016, irrespective of advanced melanoma diagnosis date
Medical history available for medical chart abstraction from date of diagnosis through most recent or current therapy (defined as end of data collection period)

Exclusion Criteria:

Physicians unwilling or unable to follow study instructions
Patients who were previously enrolled in a cancer treatment-related clinical trial since the diagnosis of unresectable stage III and/or metastatic (stage IV) melanoma

Study is for people with:

Melanoma

Estimated Enrollment:

650

Study ID:

NCT03199846

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Local Institution
Morristown New Jersey, 07960, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

650

Study ID:

NCT03199846

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider